Literature DB >> 18609698

Non-Hodgkin lymphoma as a cause of obstructive jaundice with simultaneous extrahepatic portal vein obstruction: a case report.

Masao Hashimoto1, Nobutaka Umekita, Kazumasa Noda.   

Abstract

Non-Hodgkin lymphoma is a rare cause of biliary obstruction. To the best of our knowledge, non-Hodgkin lymphoma in the peripancreatic region causing obstructive jaundice with simultaneous portal vein (PV) invasion has not yet been reported. We present a 50-year-old patient with obstructive jaundice whose extrahepatic portal vein was obstructed by the invasion of a peripancreatic non-Hodgkin lymphoma. The patient denied any other symptoms such as recurrent fever, night sweat and loss of body weight. Computed tomography (CT) revealed a 10 cm mass in the retroperitoneal space behind the head of the pancreas causing obstruction of the distal bile duct and the PV. A pylorus-preserving pancreaticoduodenectomy combined with a PV resection was performed. The PV was reconstructed using an autologous right internal jugular vein graft. The resected specimen showed endoluminal invasion of both the bile duct and the PV. Histological examination showed the mass consisting of diffuse sheets of large malignant lymphoid cells. These cells were positive for CD20 and CD79a, partially positive for CD10, and negative for CD3, CD4, CD5, CD8 and CD30. The pathologic diagnosis was diffuse large B-cell type non-Hodgkin lymphoma and the patient was transferred to the Department of Hematology and Oncology for chemotherapy. He received four cycles of combined chemotherapy including cyclophosphamide, doxorubicin, vincristine and prednisone plus rituximab, and three cycles of intrathecal chemoprophylaxis including methotorexate, cytosine arbinoside and prednisone. The patient is alive with no evidence of the disease for 7 mo after operation and will receive additional courses of chemotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18609698      PMCID: PMC2725353          DOI: 10.3748/wjg.14.4093

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  A successful right axillary artery graft to repair a ruptured axillary artery due to the involvement of lymphoma: report of a case.

Authors:  Yahya Unlü; Salim B Tekin; Münacettin Ceviz; Ahmet Balci
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

2.  Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.

Authors:  Bülent Odemiş; Erkan Parlak; Omer Başar; Osman Yüksel; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

3.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

4.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

5.  Radiologically guided percutaneous fine-needle aspiration biopsy of pelvic and retroperitoneal masses: a retrospective study of 68 cases.

Authors:  Z Guo; D F Kurtycz; L E De Las Casas; H D Hoerl
Journal:  Diagn Cytopathol       Date:  2001-07       Impact factor: 1.582

6.  Clinical utility of endoscopic ultrasound and endscopic ultrasound-guided fine needle aspiration in retroperitoneal neoplasms.

Authors:  R A Erickson; Z Tretjak
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

7.  Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA.

Authors:  Carlos Micames; Paul S Jowell; Rebekah White; Erik Paulson; Rendon Nelson; Michael Morse; Herbert Hurwitz; Theodore Pappas; Douglas Tyler; Kevin McGrath
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

8.  Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma.

Authors:  D J Dudgeon; M Brower
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

9.  Non-Hodgkin lymphoma presenting with obstructive jaundice.

Authors:  K V Ravindra; M D Stringer; K R Prasad; S E Kinsey; J P A Lodge
Journal:  Br J Surg       Date:  2003-07       Impact factor: 6.939

10.  Primary lymphoma of the liver with bile duct invasion and tumoral occlusion of the portal vein: report of a case.

Authors:  F Yoneyama; Y Nimura; J Kamiya; S Kondo; M Nagino; M Kanai; M Miyachi; K Oda
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

View more
  3 in total

1.  Periampullary lymphoma masquerading as adenocarcinoma.

Authors:  K N Lokesh; K C Lakshmaiah; C S Premalata; D Lokanatha
Journal:  Indian J Surg Oncol       Date:  2013-03-28

2.  Primary pancreatic lymphoma: two case reports and a literature review.

Authors:  Lili Yu; Yajun Chen; Ligang Xing
Journal:  Onco Targets Ther       Date:  2017-03-20       Impact factor: 4.147

3.  Obstructive jaundice as an initial manifestation of non-hodgkin lymphoma: treatment dilemma and high mortality.

Authors:  Dhara Chaudhari; Sarah Khan; Atif Saleem; Tamarro Taylor; Chakradhar Reddy; Thomas Borthwick; Mark Young
Journal:  Case Rep Med       Date:  2013-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.